Enter multiple symbols separated by commas

Stocks Eli Lilly and Co


  • UPDATE 1-FDA approves Lilly's lung cancer drug Tuesday, 24 Nov 2015 | 1:07 PM ET

    Nov 24- The U.S. Food and Drug Administration said it had approved Eli Lilly& Co's Portrazza, in combination with two forms of chemotherapy, to treat patients with a type of lung cancer. The FDA's approval on Tuesday comes about four months after an advisory panel to the agency recommended the drug be cleared for sale along with the warnings. Eli Lilly's shares were...

  • FDA approves Lilly's lung cancer drug Tuesday, 24 Nov 2015 | 12:01 PM ET

    Nov 24- The U.S. Food and Drug Administration on Tuesday approved Eli Lilly& Co's cancer treatment, Portrazza, in combination with two forms of chemotherapy to treat patients with advanced squamous non-small cell lung cancer.

  • Cramer: Most amazing transformation I've ever seen Friday, 20 Nov 2015 | 6:57 PM ET

    Jim Cramer says this week was the most amazing transformation he has ever seen before. But can the bull continue to dance?

  • LONDON, Nov 18- Pearson boss John Fallon faces a daunting task to arrest the decline of the world's biggest education publisher as it battles growing political and economic strife. Fallon has endured a rough ride since he took over in 2013, with a string of profit warnings marking his tenure, in an abrupt end to the steady growth enjoyed by his predecessor...

  • NEW YORK, Nov 17- Healthcare companies that can either contain costs or develop medications to treat rare diseases, known as orphan drugs, will be the most likely to outperform in the coming year, said John Fraunces, whose Turner Medical Sciences Long/Short fund is among the top performing healthcare funds over the last 5 years. He is shorting AbbVie Inc, for...

  • TRENTON, N.J.— Merck& Co. said Friday that it will continue a huge patient study of an experimental cholesterol medicine, the last one standing in a once-promising class of drugs being developed to prevent heart attacks, after an independent monitoring committee recommended the study continue. The study, overseen by the UK's Oxford University, began in May 2011...

  • The American Heart Association is holding its annual scientific sessions in Orlando, Florida from Nov 7 to 11, at which the latest clinical trials and research in heart care are being presented for thousands of cardiologists and researchers, including a large government-sponsored study on the benefits of more intensive blood pressure lowering in patients...

  • ORLANDO, Nov 9- Eli Lilly's new diabetes drug Jardiance significantly cut the risk of heart-related death and hospitalization for heart failure in patients with type 2 diabetes who are at high risk for serious heart problems, according to data from a large study presented on Monday. The 3- year trial of more than 7,000 patients caused a sensation in September,...

  • One of their favorite targets is Pasadena, California- based Alexandria Real Estate Equities Inc, which owns the largest collection of high-end lab space in such research clusters as San Diego, San Francisco and Cambridge, Massachusetts. That has helped push rents for lab spaces up by 7.4 percent over the last year in Boston, the nation's most expensive market...

  • LONDON, Oct 27- A cheap off-patent drug that relieves some symptoms of Alzheimer's disease may also help keep people at an advanced stage of the illness out of nursing homes, at least for a while. Donepezil, originally sold by Eisai and Pfizer as Aricept and now available generically for just over 20 pounds a year, works by raising the levels of chemicals within the...

  • Dow futures up 100 points amid Draghi remarks, data Thursday, 22 Oct 2015 | 9:24 AM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stock index futures pointed to a sharply higher open on Thursday.

  • Oct 22- Eli Lilly& Co reported sharply better-than-expected quarterly earnings due to cost controls and sales of new treatments for diabetes and cancer, keeping the U.S. drugmaker on track for its planned return to growth this year. "We are encouraged by the combination of Lilly's new product cycle coupled with expense management, which we see driving healthy...

  • Early movers: UAL, MMM, CAT, DNKN, SWK, LLY & more Thursday, 22 Oct 2015 | 7:58 AM ET
    Traders work on the floor of the New York Stock Exchange (NYSE).

    Some of the names on the move ahead of the open.

  • Big earnings and housing data to dominate Wall Street Thursday, 22 Oct 2015 | 7:05 AM ET

    U.S. stock futures were higher this morning, with the market trying to avoid its first three-session losing streak of October.

  • Bears sniffing around stocks on big earnings day Wednesday, 21 Oct 2015 | 6:01 PM ET
    Trader on the floor of the New York Stock Exchange.

    Three Dow components and dozens of other companies will report earnings Thursday morning.

  • The $100 million Dementia Discovery Fund is unusual in focusing on a single difficult-to-treat disorder and in bringing together both industry and government. The initiative was announced by British health minister Jeremy Hunt in March, following a Group of Eight nations conference in 2013 that set a goal of finding a cure or effective treatment for...

  • Halftime Trades Huge Earnings Week Monday, 19 Oct 2015 | 1:23 PM ET

    The "Halftime Report" traders give their top trades.

  • Market eyes earnings as Fed leaves it in confusion Friday, 16 Oct 2015 | 6:33 PM ET
    NYSE Traders

    So far the earnings season has been lackluster, and some high-profile warnings have already given investors pause.

  • Cramer: Trade secrets for playing the slowdown Friday, 16 Oct 2015 | 6:32 PM ET
    Bottles of Pepsi-Cola on sale in San Francisco.

    Jim Cramer arms investors with the inside mindset of how hedge funds and mutual funds will play this market slowdown.

  • Oct 16- Hong Kong- based drugmaker Hutchison China MediTech Ltd has filed for an initial public offering in the United States, according to a regulatory filing. In the corresponding period last year, the listing of 10 Chinese companies in the United States had raised over $3.5 billion, according to Thomson Reuters data. The company, which listed on the London Stock...